Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Int J Cardiol Heart Vasc ; 29: 100589, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: covidwho-642152

RESUMEN

Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic that may present with a variety of cardiac manifestations including, but not limited to, myocardial injury, myocardial infarction, arrhythmias, heart failure, cardiomyopathy, shock, thromboembolism, and cardiac arrest. These cardiovascular effects are worse in patients who have pre-existing cardiac conditions such as coronary artery disease, hypertension, diabetes mellitus, and coagulation abnormalities. Other predisposing risk factors include advanced age, immunocompromised state, and underlying systemic inflammatory conditions. Here we review the cellular pathophysiology, clinical manifestations and treatment modalities of the cardiac manifestations seen in patients with COVID-19.

2.
Cardiology Research ; 11(3):196-199, 2020.
Artículo | WHO COVID | ID: covidwho-459301

RESUMEN

A 67-year-old man with a prior heart failure presented with fever, cough and dyspnea for 4 days Physical examination showed bilateral rales on the lung exam, yet no lower extremity edema The combination of symptoms, elevated inflammatory markers, normal baseline pro-B-type natriuretic peptide, PaO2/FiO(2) < 300 and positive swab suggested coronavirus disease 2019 (COVID-19) with acute respiratory distress syndrome (ARDS) rather than heart failure exacerbation We discuss the challenges in management of ARDS in COVID-19 patients that may initially mimic as acute exacerbation of heart failure

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA